Mednet Logo

When do you discontinue PARP inhibitor maintenance after complete response to first line chemotherapy in a BRCA+ patient?

Is there a role for continuing beyond 24 months?
Community PollStarted

When should PARPi maintenance be discontinued?

73 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet Member
Medical Oncology · Christie NHS Foundation Trust
Answered on · Updated on

I agree with Dr. @Dr. First Last that we have no data for PARPi maintenance beyond 2 years in the first line and would urge people to enroll in clinical trials which look at risks and benefits of longer maintenance, especially in patients harbouring a germline BRCA mutation.

With respect to all come...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · University of Alabama at Birmingham
Answered on

Though it hasn't happened to me yet, the data would suggest no indication to continue PARPi beyond 2 years.

Join for free or sign in to see the full answer